The Effect of Dolutegravir on Whole-body Insulin Sensitivity, Lipid and Endocrine Profile in Healthy Volunteers
Clinical trial NCT04771754 · COMPLETED
Trial details
- NCT number
- NCT04771754
- Sponsor
- Chelsea and Westminster NHS Foundation Trust
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-20
- Primary completion
- 2023-12-31
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.